DKK1 has been reported as a tumor suppressor in colon cancer (CC) [118] or as an oncogene abnormally expressed in tumor cells or overexpressed in many cell lines and HCC [119], lung cancer, BC, cervical cancers, and glioma [117]. Here, DKK1 is linked to breast cancer.